• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Johns Hopkins RheumTV

Show Search
Hide Search
  • About
  • Diseases
    • Ankylosing Spondylitis
    • Inclusion Body Myositis
    • Gout
    • Inflammatory Arthritis
    • Lupus
    • Lyme Disease
    • Myositis
    • Polymyositis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Scleroderma
    • Sjögren’s Syndrome
    • Vasculitis
  • Topics
    • Disease Information
    • Exercise Tips
    • Lifestyle Tips
    • Medication Education
    • Patient Education
    • Biologic Medication Education
    • Corticosteroids
  • Contact Us
Home / RheumTV / Cancer Immunotherapy and Arthritis

Cancer Immunotherapy and Arthritis

A new type of therapy called Immunotherapy, is used to treat cancers. It’s been observed that Immunotherapy could lead to an over-activation of the immune system. In Rheumatology we’re seeing an increase in arthritis driven by this activation of the immune system. Dr. Cappelli discusses the questions she and her oncologist colleagues have about why this happens and how do we best evaluate and treat these patients.

In This Video

Laura Cappelli, MD, MHS, MS

Dr. Cappelli is an Assistant Professor of Medicine in the Johns Hopkins Division of Rheumatology. Her research focuses on inflammatory arthritis and on the effects of cancer immunotherapy.

Primary Sidebar

Related Content

  1. Rheumatoid Arthritis Disease Overview
  2. Rheumatoid Arthritis Diagnosis
  3. Psoriatic Arthritis – Disease Overview

Johns Hopkins Medicine

© 2025 Johns Hopkins Rheumatology
Patient Privacy